A disease state approach to the pharmacological management of Type 2 diabetes in primary care : A position statement by Primary Care Diabetes Europe
Copyright © 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved..
Type 2 diabetes and its associated comorbidities are growing more prevalent, and the complexity of optimising glycaemic control is increasing, especially on the frontlines of patient care. In many countries, most patients with type 2 diabetes are managed in a primary care setting. However, primary healthcare professionals face the challenge of the growing plethora of available treatment options for managing hyperglycaemia, leading to difficultly in making treatment decisions and contributing to therapeutic inertia. This position statement offers a simple and patient-centred clinical decision-making model with practical treatment recommendations that can be widely implemented by primary care clinicians worldwide through shared-decision conversations with their patients. It highlights the importance of managing cardiovascular disease and elevated cardiovascular risk in people with type 2 diabetes and aims to provide innovative risk stratification and treatment strategies that connect patients with the most effective care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Primary care diabetes - 15(2021), 1 vom: 29. Feb., Seite 31-51 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Seidu, S [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 15.10.2021 Date Revised 15.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pcd.2020.05.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311117708 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311117708 | ||
| 003 | DE-627 | ||
| 005 | 20231225141554.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pcd.2020.05.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311117708 | ||
| 035 | |a (NLM)32532635 | ||
| 035 | |a (PII)S1751-9918(20)30189-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Seidu, S |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A disease state approach to the pharmacological management of Type 2 diabetes in primary care |b A position statement by Primary Care Diabetes Europe |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.10.2021 | ||
| 500 | |a Date Revised 15.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a Type 2 diabetes and its associated comorbidities are growing more prevalent, and the complexity of optimising glycaemic control is increasing, especially on the frontlines of patient care. In many countries, most patients with type 2 diabetes are managed in a primary care setting. However, primary healthcare professionals face the challenge of the growing plethora of available treatment options for managing hyperglycaemia, leading to difficultly in making treatment decisions and contributing to therapeutic inertia. This position statement offers a simple and patient-centred clinical decision-making model with practical treatment recommendations that can be widely implemented by primary care clinicians worldwide through shared-decision conversations with their patients. It highlights the importance of managing cardiovascular disease and elevated cardiovascular risk in people with type 2 diabetes and aims to provide innovative risk stratification and treatment strategies that connect patients with the most effective care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a Cardiovascular risk factors | |
| 650 | 4 | |a Chronic kidney disease | |
| 650 | 4 | |a Elderly | |
| 650 | 4 | |a Heart failure | |
| 650 | 4 | |a Multimorbidity | |
| 650 | 4 | |a Patient-centred care | |
| 650 | 4 | |a Primary care | |
| 650 | 4 | |a Shared decision making | |
| 650 | 4 | |a Therapeutic inertia | |
| 650 | 4 | |a Type 2 diabetes | |
| 700 | 1 | |a Cos, X |e verfasserin |4 aut | |
| 700 | 1 | |a Brunton, S |e verfasserin |4 aut | |
| 700 | 1 | |a Harris, S B |e verfasserin |4 aut | |
| 700 | 1 | |a Jansson, S P O |e verfasserin |4 aut | |
| 700 | 1 | |a Mata-Cases, M |e verfasserin |4 aut | |
| 700 | 1 | |a Neijens, A M J |e verfasserin |4 aut | |
| 700 | 1 | |a Topsever, P |e verfasserin |4 aut | |
| 700 | 1 | |a Khunti, K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Primary care diabetes |d 2007 |g 15(2021), 1 vom: 29. Feb., Seite 31-51 |w (DE-627)NLM18094911X |x 1878-0210 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2021 |g number:1 |g day:29 |g month:02 |g pages:31-51 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pcd.2020.05.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2021 |e 1 |b 29 |c 02 |h 31-51 | ||